Yabe N, Matsuya Y, Yamane I, Takada M
In Vitro Cell Dev Biol. 1986 Jul;22(7):363-8. doi: 10.1007/BF02623523.
A newly developed, serum-free medium (NYSF-404) selects for antibody-producing hybridomas after fusion of antigen-sensitized mouse spleen cells with myeloma cell lines P3-X63-Ag8-U1 (P3-U1), P3-X63-Ag8-6.5.3 (Ag8.653), or P3-NSI/1-Ag4-1 (NS-1). Without the need for hypoxanthine-aminopterin-thymidine (HAT) selection of hybrid cells, frequency of hybridoma formation in medium NYSF-404 is higher (twice) than that in serum- and HAT-containing medium. Colonies developed upon limiting dilution in the presence of the mortal parent myeloma cells in medium NYSF-404 and pure culture of antibody-secreting cells could be subsequently established. The results suggest that fusions can be done in serum-free medium and that the clonal growth of hybridomas is dependent on factors produced by parent myeloma cells under serum-free culture conditions. Such factors seem deficient in serum- and HAT-containing medium or are masked by serum.
一种新开发的无血清培养基(NYSF - 404),可在抗原致敏的小鼠脾细胞与骨髓瘤细胞系P3 - X63 - Ag8 - U1(P3 - U1)、P3 - X63 - Ag8 - 6.5.3(Ag8.653)或P3 - NSI/1 - Ag4 - 1(NS - 1)融合后,筛选出产生抗体的杂交瘤。无需对杂交细胞进行次黄嘌呤 - 氨基蝶呤 - 胸腺嘧啶核苷(HAT)选择,NYSF - 404培养基中杂交瘤形成的频率比含血清和HAT的培养基高(两倍)。在NYSF - 404培养基中,在有致死性亲本骨髓瘤细胞存在的情况下通过有限稀释形成的集落,随后可建立抗体分泌细胞的纯培养。结果表明,可以在无血清培养基中进行融合,并且杂交瘤的克隆生长依赖于无血清培养条件下亲本骨髓瘤细胞产生的因子。此类因子在含血清和HAT的培养基中似乎缺乏,或者被血清掩盖。